期刊文献+

肝X受体在肥胖或高血糖状态下的表达及其对肝PEPCK表达的影响 被引量:1

Expression of LXR in rats with obesity or hyperglycemia and its impact on PEPCK expression in liver
下载PDF
导出
摘要 目的:观察在大鼠肥胖或高血糖状态下肝内肝X受体(LXR)表达的变化情况及其对下游靶基因11β-羟基类固醇脱氢酶1(11β-HSD1)mRNA和磷酸烯醇式丙酮酸羧激酶(PEPCK)mRNA表达的调节作用,探讨LXR信号通路对糖代谢的影响机制。方法:SD雄鼠27只分为正常对照(CON)组、糖尿病(DM)组和肥胖(OB)组,后2组诱导成模后测定各组大鼠的体质量、血糖、胆固醇和三酰甘油。对CON组和OB组大鼠行腹部MRI检查、正葡萄糖高胰岛素钳夹试验和肝脏病理切片检查,采用实时荧光定量PCR检测各组大鼠肝脏LXR mRNA、PEPCK mRNA和11β-HSD1 mRNA的表达情况。结果:MRI及肝病理切片显示OB组大鼠腹腔脂肪严重堆积及脂肪肝形成,OB组大鼠较CON组具有明显的胰岛素抵抗。与CON组相比,各实验组大鼠肝LXR mRNA表达均显著升高,11β-HSD1 mRNA表达均显著下降,OB组肝PEPCK mRNA表达明显下调,DM组肝PEPCK mRNA表达较明显上调(P均<0.05)。结论:在肥胖状态下,LXR可能作为糖代谢的保护性受体,通过调节肝糖代谢酶,使血糖保持稳态;进入糖尿病阶段后,LXR的保护作用并不能逆转因胰岛素不足所致的糖代谢相关酶的异常改变,因而血糖升高。 Objective To investigate the expression of LXR in rats with obesity or hyperglycemia and its impact on the regulation of expressions of 11β-HSD1 mRNA and PEPCK mRNA to study the mechanism of impact of LXR signal pathway on glucose metabolism.Methods Twenty-seven male SD rats were modeled and categorized into three groups: normal control(CON) group,obesity(OB) group and diabetes mellitus(DM) group.Weight,blood glucose,serum triglyceride and cholesterol were measured to estimate the metabolic status.Abdominal MRI and liver biopsy were performed to estimate fat accumulation,and glucose clamp test was performed to estimate the insulin resistance status.Then the rats were sacrificed and liver was taken for pathological examination.Real-time PCR was used to determine the liver expression of LXR mRNA,PEPCK mRNA and 11β-HSD1 mRNA.Results MRI and the liver pathological study showed that the OB group had severe abdominal fat accumulation and fatty liver.And the glucose clamp test showed that the rats in OB group had obvious insulin resistance.Comparing to CON group,the LXR mRNA expression was significantly higher and the 11β-HSD1 mRNA expression was significantly lower in OB and DM groups;PEPCK mRNA expression decreased significantly in OB group,while it was significantly higher in DM group(P0.05).Conclusions In obesity status,LXR as a protective receptor of glucose metabolism may keep glucose homeostasis through regulating hepatic glucose metabolic enzymes.Whereas in diabetes period,the protective effect of LXR could not reverse the abnormal alteration of glucose metabolism related enzymes caused by insufficiency of insulin,thereby blood glucose is elevated.
作者 董莹 刘伟
出处 《诊断学理论与实践》 2010年第6期581-585,共5页 Journal of Diagnostics Concepts & Practice
基金 上海市卫生局科研课题基金资助项目(2008083)
关键词 糖尿病 肝X受体 11Β-羟基类固醇脱氢酶1 磷酸烯醇式丙酮酸羧激酶 肥胖 Diabetes Liver X receptor 11beta-hydroxysteroid dehydrogenase type 1 Phosphoenolpyruvate carboxykinase Obesity
  • 相关文献

参考文献15

  • 1刘阳,常永生,方福德.肝X受体:糖和脂代谢中的重要调节者[J].中国医学科学院学报,2007,29(3):430-435. 被引量:6
  • 2Dalen KT, Ulven SM, Bambery K, et al. Expression of the insulin-responsive glucose transporter GluT4 in adipocytes is dependent on liver X receptor alpha [J]. J Biol Chem, 2003, 278(48):48283-48291.
  • 3黄琛,顾志峰,曹晓蕾,印彤,余江毅,朱晓晖,王粹芳,崔世维.1型糖尿病大鼠模型建立及稳定性研究[J].现代检验医学杂志,2007,22(3):49-51. 被引量:19
  • 4郭啸华,刘志红,李恒,黎磊石.高糖高脂饮食诱导的2型糖尿病大鼠模型及其肾病特点[J].中国糖尿病杂志,2002,10(5):290-294. 被引量:304
  • 5Yang W, Lu J, Weng J, et al. Prevalence of diabetes among men and women in China[J]. N Engl J Med, 2010, 362 (12):1090-1101.
  • 6Imai E, Stromstedt PE, Quinn PG, et al.Characterization of a complex glucocorticoid response unit in the phosphoenolpyruvate carboxykinase gene [J]. Mol Cel Biol, 1990, 10(9): 4712-4719.
  • 7Kalaany NY, Mangelsdorf DJ. LXRS and FXR: the yin and yang of cholesterol and fat metabolism[J]. Annu Rev Physiol, 2006, 68:159-191.
  • 8Stulnig TM, Steffensen KR, Gao H, et al. Novel roles of liver X receptors exposed by gene expression profiling in liver and adipose tissue [J]. Mol pharmacol, 2002, 62: 1299-1305.
  • 9Steffensen KR, Gustafsson JA. Putative metabolic effects of the liver X receptor (LXR)[J], Diabetes, 2004, 53(Suppl 1): S36-S42.
  • 10Stulnig TM, Steffensen KR, Gao H, et al. Novel roles of liver X receptor exposed by gene expression profiling in liver and adipose tissue [J]. Mol Pharmacol, 2002, 62(6): 1299-1305.

二级参考文献71

  • 1张均田.现代药理试验方法[M].北京:北京医科大学、中国协和医科大学联合出版社,1998.1425-1452.
  • 2Bergman RN, Finegood DT, Ader M. Assessment of insulin sensitivity in vivo. Endocrine Reviews, 1985,6 : 45-86.
  • 3Bryer-Ash M, Foilett L, Hodges N, et al. Amylin-mediated reduction in insulin sensitivity corresponds to reduced insulin receptor activity in the rat in vivo. Metabolism, 1995,44:705-711.
  • 4Proietto J, Filippis A, Nakhla C, et al. Nutrient-induced insulin resistance. Mol Cell Endocrinol, 1999,151:143-149.
  • 5Fioretto P, Mauer M, Brocco E, et al. Patterns of renal injury in NIDDM patients with microalbuminuria. Diabetologia,1996,39:1569-1576.
  • 6Joles JA, Kunter U, Janssen U, et al. Early mechanisms of renal injury in hypercholesterolemic or hypertriglyceridemic rats.J Am Soc Nephrol, 2000,11 : 669-683.
  • 7Dominguez JH, Tang N, Xu W, et al. Studies of renal injury Ⅲ: lipid-induced nephropathy in type Ⅱ diabetes. Kidney Int,2000,57 : 92-104.
  • 8Ravid M, Brosh D, Ravid-Safran D, et al. Main risk factors for nephropathy in type 2 diabetes mellitus are plasma cholesterol levels, mean blood pressure, and hyperglycemia. Arch Inter Mecl, 1998,158:998-1004.
  • 9Daniels MC, McClain DA, Crook ED. Transcriptional regulation of transforming growth factor beta by glucose: investigation into the role of the hexosamine biosynthesis pathway. Am J Med Sci, 2000,319:138-142.
  • 10Michel O, Heudes D, Lamarre I, et al. Reduction of insulin and triglycerides delays glomerulosclerosis in obese Zucker rats. Kidney Int, 1997,52:1532-1542.

共引文献324

同被引文献5

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部